Homo sapiens Protein: APC | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||||||||||||||||||
InnateDB Protein | IDBP-485228.4 | ||||||||||||||||||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||||||||||||||||||
Gene Symbol | APC | ||||||||||||||||||||||||||||||||||||||||||||
Protein Name | adenomatous polyposis coli | ||||||||||||||||||||||||||||||||||||||||||||
Synonyms | BTPS2; DP2; DP2.5; DP3; GS; PPP1R46; | ||||||||||||||||||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000427089 | ||||||||||||||||||||||||||||||||||||||||||||
InnateDB Gene | IDBG-37007 (APC) | ||||||||||||||||||||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||||||||||||||||||
Function | Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization. {ECO:0000269PubMed:10947987, ECO:0000269PubMed:17599059, ECO:0000269PubMed:19151759, ECO:0000269PubMed:19893577, ECO:0000269PubMed:20937854}. | ||||||||||||||||||||||||||||||||||||||||||||
Subcellular Localization | Cell junction, adherens junction. Cytoplasm, cytoskeleton. Cell projection, lamellipodium. Cell projection, ruffle membrane. Cytoplasm. Cell membrane. Note=Associated with the microtubule network at the growing distal tip of microtubules. Accumulates in the lamellipodium and ruffle membrane in response to hepatocyte growth factor (HGF) treatment. The MEMO1-RHOA-DIAPH1 signaling pathway controls localization of the phosophorylated form to the cell membrane. | ||||||||||||||||||||||||||||||||||||||||||||
Disease Associations | Familial adenomatous polyposis (FAP) [MIM:175100]: A cancer predisposition syndrome characterized by adenomatous polyps of the colon and rectum, but also of upper gastrointestinal tract (ampullary, duodenal and gastric adenomas). This is a viciously premalignant disease with one or more polyps progressing through dysplasia to malignancy in untreated gene carriers with a median age at diagnosis of 40 years. {ECO:0000269PubMed:10470088, ECO:0000269PubMed:1338691, ECO:0000269PubMed:1338764, ECO:0000269PubMed:1338904, ECO:0000269PubMed:1651563, ECO:0000269PubMed:7833149, ECO:0000269PubMed:7833931, ECO:0000269PubMed:8990002}. Note=The disease is caused by mutations affecting the gene represented in this entry.Hereditary desmoid disease (HDD) [MIM:135290]: Autosomal dominant trait with 100% penetrance and possible variable expression among affected relatives. HDD patients show multifocal fibromatosis of the paraspinal muscles, breast, occiput, arms, lower ribs, abdominal wall, and mesentery. Desmoid tumors appears also as a complication of familial adenomatous polyposis. {ECO:0000269PubMed:10782927, ECO:0000269PubMed:8940264}. Note=The disease is caused by mutations affecting the gene represented in this entry.Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269PubMed:10666372}. Note=The gene represented in this entry may be involved in disease pathogenesis.Mismatch repair cancer syndrome (MMRCS) [MIM:276300]: An autosomal recessive, rare, childhood cancer predisposition syndrome encompassing a broad tumor spectrum. This includes hematological malignancies, central nervous system tumors, Lynch syndrome-associated malignancies such as colorectal tumors as well as multiple intestinal polyps, embryonic tumors and rhabdomyosarcoma. Multiple cafe-au-lait macules, a feature reminiscent of neurofibromatosis type 1, are often found as first manifestation of the underlying cancer. Areas of skin hypopigmentation have also been reported in MMRCS patients. {ECO:0000269PubMed:7661930}. Note=The gene represented in this entry may be involved in disease pathogenesis.Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The gene represented in this entry may be involved in disease pathogenesis.Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. Note=The gene represented in this entry may be involved in disease pathogenesis. | ||||||||||||||||||||||||||||||||||||||||||||
Tissue Specificity | Expressed in a variety of tissues. | ||||||||||||||||||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 194 experimentally validated interaction(s) in this database.
They are also associated with 44 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||||||||||||||||||
InterPro |
IPR000225
Armadillo IPR009223 Adenomatous polyposis coli protein, cysteine-rich repeat IPR009224 SAMP IPR009232 EB-1 binding IPR009234 Adenomatous polyposis coli protein basic domain IPR009240 Adenomatous polyposis coli protein, 15 residue repeat IPR016024 Armadillo-type fold IPR026831 Adenomatous polyposis coli domain |
||||||||||||||||||||||||||||||||||||||||||||
PFAM |
PF00514
PF05923 PF05924 PF05937 PF05956 PF05972 PF11414 |
||||||||||||||||||||||||||||||||||||||||||||
PRINTS | |||||||||||||||||||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||||||||||||||||||
SMART |
SM00185
|
||||||||||||||||||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||||||||||||||||||
SwissProt | P25054 | ||||||||||||||||||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-P25054 | ||||||||||||||||||||||||||||||||||||||||||||
TrEMBL | Q9UM98 | ||||||||||||||||||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||||||||||||||||||
Entrez Gene | 324 | ||||||||||||||||||||||||||||||||||||||||||||
UniGene | Hs.739006 | ||||||||||||||||||||||||||||||||||||||||||||
RefSeq | NP_001120982 | ||||||||||||||||||||||||||||||||||||||||||||
HUGO | HGNC:583 | ||||||||||||||||||||||||||||||||||||||||||||
OMIM | 611731 | ||||||||||||||||||||||||||||||||||||||||||||
CCDS | CCDS4107 | ||||||||||||||||||||||||||||||||||||||||||||
HPRD | 01439 | ||||||||||||||||||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||||||||||||||||||
EMBL | AB210001 AC008575 AC136500 AH009132 AH009913 CH471086 EF026097 EF432779 EU681189 M73548 M74088 S67788 S78214 | ||||||||||||||||||||||||||||||||||||||||||||
GenPept | AAA03586 AAA60353 AAA60354 AAB21145 AAD13998 AAF34355 AAG25599 ABL98125 ABQ09217 ABQ09218 ABQ09219 ABQ09220 ACD11098 BAE06083 EAW49002 EAW49007 | ||||||||||||||||||||||||||||||||||||||||||||